These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 3450455)

  • 21. The utility of the gonadotrophin releasing hormone (GnRH) test in the diagnosis of polycystic ovary syndrome (PCOS).
    Lewandowski KC; Cajdler-Łuba A; Salata I; Bieńkiewicz M; Lewiński A
    Endokrynol Pol; 2011; 62(2):120-8. PubMed ID: 21528473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of long term testosterone administration on pulsatile luteinizing hormone secretion and on ovarian histology in eugonadal female to male transsexual subjects.
    Spinder T; Spijkstra JJ; van den Tweel JG; Burger CW; van Kessel H; Hompes PG; Gooren LJ
    J Clin Endocrinol Metab; 1989 Jul; 69(1):151-7. PubMed ID: 2471710
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the inappropriate gonadotropin secretion of patients with polycystic ovary syndrome similar to that of patients with adult-onset congenital adrenal hyperplasia?
    Levin JH; Carmina E; Lobo RA
    Fertil Steril; 1991 Oct; 56(4):635-40. PubMed ID: 1915936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polycystic ovarian morphology with regular ovulatory cycles: insights into the pathophysiology of polycystic ovarian syndrome.
    Adams JM; Taylor AE; Crowley WF; Hall JE
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4343-50. PubMed ID: 15356031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S; Taylor AE; Martin KA; Welt CK; Adams JM; Hall JE
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effect of sequential administration of octreotide alone and octreotide/growth hormone simultaneously on buserelin stimulated ovarian steroid secretion in women with polycystic ovary syndrome.
    Piaditis GP; Hatziioanidis AH; Trovas GP; Misichronis GS; Kounadi TG; Devetzaki OA; Andronis CK; Rangou DB; Chlouverakis CS
    Clin Endocrinol (Oxf); 1996 Nov; 45(5):595-604. PubMed ID: 8977757
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood flow changes in the ovarian and uterine arteries in women with polycystic ovary syndrome who respond to clomiphene citrate: correlation with serum hormone concentrations.
    Zaidi J; Jacobs H; Campbell S; Tan SL
    Ultrasound Obstet Gynecol; 1998 Sep; 12(3):188-96. PubMed ID: 9793191
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Dexamethasone does not normalize disordered LH pulsatility in hyperandrogenemic ovarian insufficiency].
    Graf M; Weiers C; Graf C; Umlauf A; Distler W
    Geburtshilfe Frauenheilkd; 1992 Jan; 52(1):35-41. PubMed ID: 1547932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pulsatile gonadotrophin secretion in women with polycystic ovary syndrome after gonadotrophin-releasing hormone agonist treatment.
    Cheung AP; Lu JK; Chang RJ
    Hum Reprod; 1997 Jun; 12(6):1156-64. PubMed ID: 9221993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mid-follicular phase pulses of inhibin B are absent in polycystic ovarian syndrome and are initiated by successful laparoscopic ovarian diathermy: a possible mechanism regulating emergence of the dominant follicle.
    Lockwood GM; Muttukrishna S; Groome NP; Matthews DR; Ledger WL
    J Clin Endocrinol Metab; 1998 May; 83(5):1730-5. PubMed ID: 9589683
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hormonal effects of flutamide in young women with polycystic ovary syndrome.
    De Leo V; Lanzetta D; D'Antona D; la Marca A; Morgante G
    J Clin Endocrinol Metab; 1998 Jan; 83(1):99-102. PubMed ID: 9435423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Women with oligo-/amenorrhoea and polycystic ovaries have identical responses to GnRH stimulation regardless of their androgen status: comparison of the Rotterdam and Androgen Excess Society diagnostic criteria.
    Lewandowski KC; Cajdler-Luba A; Bieńkiewicz M; Lewiński A
    Neuro Endocrinol Lett; 2011; 32(6):847-56. PubMed ID: 22286802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Muting of androgen negative feedback unveils impoverished gonadotropin-releasing hormone/luteinizing hormone secretory reactivity in healthy older men.
    Veldhuis JD; Zwart A; Mulligan T; Iranmanesh A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):529-35. PubMed ID: 11158004
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The hormonal response of patients with polycystic ovarian disease to subcutaneous low frequency pulsatile administration of luteinizing hormone-releasing hormone.
    Hurwitz A; Rosenn B; Palti Z; Ebstein B; Har-Nir R; Ron M
    Fertil Steril; 1986 Sep; 46(3):378-84. PubMed ID: 2943606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of bromocryptin in polycystic ovary syndrome].
    Fuhrer J; Cheviakoff S; Rubio V
    Rev Chil Obstet Ginecol; 1989; 54(6):364-9; discussion 369-70. PubMed ID: 2485372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gonadotropic axis in hyperandrogenic adolescents.
    Taylor AE
    J Pediatr Endocrinol Metab; 2000; 13 Suppl 5():1281-4. PubMed ID: 11117670
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibitory effect of bromocriptine treatment on luteinizing hormone secretion in polycystic ovary syndrome.
    Falaschi P; Rocco A; del Pozo E
    J Clin Endocrinol Metab; 1986 Feb; 62(2):348-51. PubMed ID: 3510225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inappropriate gonadotropin secretion in polycystic ovary syndrome: influence of adiposity.
    Arroyo A; Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Nov; 82(11):3728-33. PubMed ID: 9360532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine features of polycystic ovary syndrome in a random population sample of 14-16 year old adolescents.
    van Hooff MH; Voorhorst FJ; Kaptein MB; Hirasing RA; Koppenaal C; Schoemaker J
    Hum Reprod; 1999 Sep; 14(9):2223-9. PubMed ID: 10469684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.